International Journal of Thyroidology

Table. 1.

Table. 1.

Clinical course and laboratory findings in the two cases

Case
no
Age Free T4 (ng/dL)
[Reference]
TSH (μU/mL)
[Reference]
Ht/Wt
(cm/kg)
Dx Tx course
(Dose μg/kg)
1 NST 36.1 [0.5-10]
2 wk 0.5 [0.9-2.6] >150 [0.5-10] Start T4 12.5
2.8 yr 1.51 [0.8-2.2] 0.45 [0.5-4.8] 91/14 On T4 3.57
3.1 yr 0.95 16.4 ND/15.2 RI After trial-off
3.6 yr 1.42 0.84 Restart T4 3.36
4.1 yr 1.14 1.71 100.1/16.4 On T4 3.05
4.6 yr 0.99 5.16 US After trial-off
5.1 yr 1.05 2.31 ND/18 Off T4
6.0 yr 0.8 12.28 114.6/19.9 Off T4
6.1 yr 1.05 2.31 Restart T4 1.39
7.0 yr 1.29 0.93 120.7/24.9 NGS On T4 1.00
2 NST 3.3* [>2.3] 76.3 [0.5-10.0] ND/2.9
2 wk 0.29 [0.9-2.6] >50 [0.5-10.0] 50.6/3.4 Start T4 9.71
1.5 yr 1.75 [0.8-2.2] 1.62 [0.5-4.8] 85/12 On T4 2.08
2.1 yr 1.9 9.76 92/13 RI After trial-off
2.5 yr 1.0 9.0 ND/14 Off T4
3.0 yr 1.1 8.6 Off T4
4.1 yr 0.58 28.8 100.7/16.5 RI Off T4
4.3 yr 1.78 0.38 102.7/17 Restart T4 3.03
14.5 yr 1.22 [0.8-2.3] 1.58 156.8/50.6 US, NGS On T4 0.98

Dx: diagnostics, Free T4: free thyroxine, Ht/Wt: height/weight, ND: no data, NGS: next-generation sequencing, NST: neonatal screening test, RI: radionuclide scan, T4: levothyroxine, TSH: thyroid-stimulating hormone, Tx: treatment, US: ultrasound scan, wk: weeks, yr: years

*Total T4 (μg/dL).

Int J Thyroidol 2022;15:54-9 https://doi.org/10.11106/ijt.2022.15.1.54
© 2022 Int J Thyroidol